Rapid onset of peripheral artery disease in a chronic myeloid leukemia patient without prior arterial disorder: direct relationship with nilotinib exposure and clinical outcome-Reference-Cited by-同舟云学术

Rapid onset of peripheral artery disease in a chronic myeloid leukemia patient without prior arterial disorder: direct relationship with nilotinib exposure and clinical outcome

Published:2014-08-23 Issue:4 Volume:94 Page:363-367
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Mirault Tristan¹²³,Rea Delphine⁴,Azarine Arshid⁵,Messas Emmanuel¹²³

Affiliation:

1. Médecine Vasculaire; Hôpital Européen Georges-Pompidou; AP-HP; Paris France

2. Sorbonne Paris Cité; Université Paris Descartes; Paris France

3. INSERM U970; PARCC; Paris France

4. Hématologie Adulte; Hôpital Saint-Louis; AP-HP; Paris France

5. Radiologie; Hôpital Européen Georges-Pompidou; AP-HP; Paris France

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12367/fullpdf

Reference24 articles.

1. Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib;Gambacorti-Passerini;J Natl Cancer Inst,2011

2. Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008;Björkholm;J Clin Oncol,2011

3. Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy;Huang;Cancer,2012

4. Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl;Weisberg;Cancer Cell,2005

5. Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance;Kantarjian;Blood,2007

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Limb Salvage Surgery for Ponatinib-Induced Bilateral Chronic Limb-Threatening Ischemia in a Patient with Chronic Myeloid Leukemia with T315I Mutation in BCR-ABL: A Case Report;Annals of Vascular Diseases;2023

2. Vascular disease during cancer therapy;Cardio-Oncology Practice Manual : a Companion to Braunwald 's Heart Disease;2023

3. Ultrasound arterial anomalies in patients exposed to nilotinib therapy for chronic myeloid leukemia;JMV-Journal de Médecine Vasculaire;2021-04

4. A Case of Multiple Arterial Stenoses due to Long-term Nilotinib Exposure;Japanese Journal of Neurosurgery;2021

5. Vascular toxic effects of cancer therapies;Nature Reviews Cardiology;2020-03-26